• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avalo Therapeutics Inc (NQ: AVTX )

    8.992 -0.508 (-5.35%)
    Streaming Delayed Price Updated: 3:55 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 33,766
    Open 9.440
    Bid (Size) 8.800 (2)
    Ask (Size) 9.990 (3)
    Prev. Close 9.500
    Today's Range 8.801 - 9.440
    52wk Range 0.0333 - 34.46
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Avalo Announces Participation in September Investor Conferences
    From Avalo Therapeutics
    Via GlobeNewswire
    Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    +3.23%
    +3.23%
    1 Month
    +13.67%
    +13.67%
    3 Month
    -28.70%
    -28.70%
    6 Month
    -49.77%
    -49.77%
    1 Year
    +7494.17%
    +7494.17%

    More News

    Read More
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    The 3 Best Personalized Nutrition Stocks to Buy Now
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
    From Avalo Therapeutics
    Via GlobeNewswire
    Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
    From Avalo Therapeutics
    Via GlobeNewswire
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    AVTX Stock Earnings: Avalo Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
    From Avalo Therapeutics
    Via GlobeNewswire
    Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Avalo Reports 2023 Financial Results and Provides Business Updates
    From Avalo Therapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.